Management of patients after renal graft loss: An open question for nephrologists

Renal Failure

Volumn 28, Issue 3, 2006, Pages 203-210

  Coppolino, Giuseppe ^a   Criseo, Manila ^a   Nostro, Lorena ^a   Floccari, Fulvio ^a   Aloisi, Carmela ^a   Romeo, Adolfo ^a   Frisina, Nicola ^a   Buemi, Michele ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE   (Italy)

Author keywords

Graft failure; QOL; Transplantation failure

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; HLA ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ARTERIOVENOUS FISTULA; CARDIOVASCULAR RISK; ECONOMIC ASPECT; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NEPHRECTOMY; NUTRITIONAL STATUS; PRIORITY JOURNAL; QUALITY OF LIFE; RECIPIENT; REVIEW; SUBSTITUTION THERAPY; SURGICAL PATIENT; SURVIVAL; VASCULAR ACCESS;

HUMANS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; NEPHROLOGY; RENAL DIALYSIS; RENAL INSUFFICIENCY; TREATMENT FAILURE;

EID: 33745728299     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220600580357     Document Type: Review

References (51)

1. Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med. 1994;331(6):365-376.
2. Wolfe R, Ashby V, Milford E, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725-1730.
3. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 1996;50:235-242.
4. US Renal Data System. USRDS 2003 Annual Data Report. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD, 2003.
5. Cancarini GC, Sandrini S, Setti G, Bossini N, Maiorca P, Guerini S, Cassamali S, Pertica N, Turina S, Maiorca R Renal transplantation and peritoneal dialysis. Contrib Nephrol. 2003;140:242-250.
6. Santos J, Martins L, Queiros J. After first graft loss: regraft or stay on dialysis? A comparative study. Transplant Proce. 2000;32:2617-2619.
7. Matas AJ, Tellis VA, Veith FJ, Kuemmel P, Mollenkopf F, Karwa G, Soberman RJ. The fate of the patient returned to hemodialysis after losing a renal transplant. JAMA. 1983;250(8):1053-1056.
8. Ojo AO, Wolfe RA, Agodoa LY, Held PJ, Port FK, Leavey SF, et al. Prognosis after primary renal transplant failure and beneficial effects of repeat transplantation. Transplantation. 1998;66:1651-1659.
9. Patard JJ, Bensalah K, Lucas A, Rodriguez A, Manunta A, Rivalan J, Le Pogamp P, Lobel B, Guille F. Management of vascular access for hemodialysis after successful kidney transplantation. Scand J Urol Nephrol. 2002;36(5):373-376.
10. Unger P, Wissing M, De Pauw L, et al. Reduction of left ventricular diameter and mass after surgical arteriovenous fistula closure in renal transplant recipients. Transplantation. 2002;74:73-79.
11. Meeus F, Kourilsky O, Guerin AP, Gaudry C, et al. Pathophysiology of cardiovascular disease in hemodialysis patients. London, KI, 2000.
12. De Lima JJ, Vieira ML, Molnar LJ, Medeiros CJ, Ianhez LE, Krieger EM. Cardiac effects of persistent hemodialysis arteriovenous access in recipients of renal allograft. Cardiology. 1999;92(4):236-239.
13. Secin FP, Rovegno AR, del Rosario Brunet M, Marrugat RE, Davalos Michel M, Fernandez HJ. Cumulative incidence, indications, morbidity and mortality of transplant nephrectomy and the most appropriate time for graft removal: only non-functioning transplants that cause intractable complications should be excised. Urology. 2003;169(4):1242-1246.
14. Sinha SN, Castro JE. Allograft nephrectomy. Br J Urol. 1976;48:413-417.
15. Burgos Sevilla FJ, Azcue LO, Del Hoyo Campos J, Rodriguez R, Marcen Letosa R, Gomez Dosantos V, et al. Trasplantectomi'a del injerto renal. Arch Esp Urol. 1994;47:255.
16. Rodriguez Garcia J, Garcia Buitron J, Chantada Abal V, Garcia Freire C, Picallo Sanchez J, Gonzalez Martin M, et al. Renal transplantectomy. Actas Urol Esp. 1992;16:25.
17. Voesten HG, Slooff MJ, Hooykaas JA, Tegzess AM, Kootstra G. Safe removal of failed transplant kidneys. Br J Surg. 1982;69:480.
18. Gustaffson A, Groth CG, Halgrimson CG, Penn I, Starzl TE. The fate of failed renal homografts retained after retransplantation. Surg Gynecol Obstet. 1973;137:40.
19. Toledo-Pereyra LH, Gordon C, Kaufmann R, Whitten JI, Mittal VK. Role of immediate versus delayed nephrectomy for failed renal transplants. Am Surg. 1987;53:534.
20. Mazzucchi E, Nahas WC, Antonopoulos IM, Piovesan AC, Ianhez LE, Arap S. Surgical complications of graft nephrectomy in the modem transplant era. J Urol. 2003;170(3):734-737.
21. Arnold ML, Pei R, Spriewald B, Wassmuth R. Anti-HLA class II antibodies in kidney retransplant patients. Tissue Antigens. 2005;65:370-378.
22. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 1969;280:735-739.
23. Lee PC, Terasaki PI, Takemoto SK. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation. 2002;74:1192-1194.
24. Worthington JE, Martin S, Al Husseini DM, Dyer PA, Johnson RW. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation. 2003;75:1034-1040.
25. Coupel S, Giral-Classe M, Karam G. Ten-year survival of second kidney transplants: impact of immunologic factors and renal function at 12 months. Kidney Int. 2003;64:674-680.
26. Khakhar AK, Shahinian VB, House AA. The impact of allograft nephrectomy on percent panel reactive antybody and clinical outcome. Transplant Proc. 2003;35:862-863.
27. Danovitch GM. How should the immunosuppressive regimen be managed in patients with established chronic allograft failure? Kidney Int Suppl. 2002;80:68-72.
28. Kiberd BA, Belitsky P. The fate of the failed renal transplant. Transplantation. 1995;59(4):645-647.
29. Jassal SV, Lok CE, Walele A, Bargman JM. Continued transplant immunosuppression may prolong survival after return to peritoneal dialysis: results of a decision analysis. Am J Kidney Dis. 2002;40(1):178-183.
30. Smak Gregoor PJ, Zietse R, van Saase JL, op de Hoek CT, IJzermans JN, Lavrijssen AT, de Jong GM, Kramer P, Weimar W. Immunosuppression should be stopped in patients with renal allograft failure. Clin Transplant. 2001;15(6):397-401.
31. Baines LS, Joseph JT, Jindal RM. Emotional issues after kidney transplantation: a prospective psychotherapeutic study. Clin Transplant. 2002;16(6):455-460.
32. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association: Washington, DC, 1994.
33. Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev. 1986;4(3):167-226.
34. Buemi M, Caccamo C, Floccari F, Coppolino G, Tripodo D, Giacobbe MS, Senatore M, Aloisi C, Ruello A, Sturiale A, Ientile R, Crisafulli G, Coppolino S, Villari A, Frisina N. Correlation between quality of life assessment and a personality neurobiological model in dialyzed patients. J Nephrol. 2003;16:895-902.
35. Dew MA, Switzer GE, Goycoolea JM, Allen AS, DiMartini A, Kormos RL, Griffith BP. Does transplantation produce quality of life benefits? A quantitative analysis of the literature. Transplantation. 1997;64(9):1261-1273.
36. Gill JS, Abichandani R, Khan S, Kausz AT, Pereira BJ. Opportunities to Improve the Care of Patients with Kidney Transplant Failure. Kidney Int. 2002;61(2002):2193-2200.
37. Arias M, Escallada R, de Francisco AL, Rodrigo E, Fernandez-Fresnedo G, Setien MA, Pinera C, Ruiz JC, Herraez I, Cotorruelo J. Return to dialysis after renal transplantation Which would be the best way? Kidney Int Suppl. 2002;80:85-88.
38. NFK-DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. National Kidney Foundation: New York, 1997.
39. Hakim RM, Lazarus JM. Initiation of dialysis. J Am Soc Nephrol. 1995;6(5):1319-1328.
40. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39(Suppl 1):S1-S000.
41. Burkart JM. Clinical experience: how much earlier should patients really start renal replacement therapy? J Am Soc Nephrol. 1998;9(12 Suppl):S118-S123.
42. Slingeneyer A, De Vecchi A, Faller B, et al. Multicenter study on patient referral to dialysis. J Am Soc Nephrol. 1998;9:226A.
43. Duman S, Asci G, Toz H, Ozkahya M, Ertilav M, Sezis M, Ok E. Patients with failed renal transplant may be suitable for peritoneal dialysis. Int Urol Nephrol. 2004;36(2):249-252.
44. Lowrie EC, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990;15:458-482.
45. Owen WF Jr, Lew NL, Liu Y, et al. The urea reduction ratio and serum albumin concentration as predictors of mortality inpatients undergoing hemodialysis. N Engl J Med. 1993;329:1001-1006.
46. Rottembourg J. Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int. 1993;43:S106-S110.
47. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32:112-119.
48. Wizemann V, Timio M, Alpert MA, et al. Options in dialysis therapy: significance of cardiovascular findings. Kidney Int. 1993;43(suppl 40):S85-91.
49. Valderrabano F, Perez-Garcia R, Junco E. How to prescribe optimal hemodialysis. Nephrol Dial Transplant. 1996;11(Suppl 2):60-67.
50. Santoro A, Mancini E, Zucchelli P. The impact of hemofiltration on the systemic cardiovascular response. Nephrol Dial Transplant. 2000;15(Suppl 2):49-54.
51. Ledebo I. Acid-base correction and convective dialysis therapies. Nephrol Dial Transplant. 2000;15(Suppl 2):45-48.